Drug Alerts and Statements
FDA Drug Alerts and Statements
FDA qualifies drug development tool to facilitate clinical trial research on alcohol use disorder
FDA qualifies drug development tool to facilitate clinical trial research on alcohol use disorder
Individual Case Safety Reports
This web page is dedicated to the health and regulatory data standard: Individual Case Safety Report
China smartphone market, 4Q 2024
Smartphone shipments in the Chinese market are expected to reach 78.6 million units in the fourth quarter of 2024, with…
GlobalWafers maintains course amid US CHIPS Act funding uncertainty
Reports indicate that the Trump administration is considering revising incentive agreements under the CHIPS and Science Act (commonly referred to…
Intel-TSMC partnership: potential semiconductor power shift?
The semiconductor industry is bracing for a potential shake-up amid reports that the US government is pushing for Intel to…
Walsin subsidiary Silitech enters energy sector with JPY6.75 billion investment in FDK
Silitech Technology, a subsidiary of Walsin Technology, has invested JPY6.75 billion (approx. NT$14.4 billion) to acquire a 45% stake in…
Taiwan IC designers navigate fragmented AIoT market, balancing customization and modularity
The growing AIoT sector presents a stark departure from traditional supply chain models that Taiwanese chip manufacturers have long relied…
JDI exits LCD production, pivots to OLED and advanced packaging with Taiwan partnership
Japan Display Inc. (JDI) announced a major restructuring plan that includes ending LCD production, transitioning to OLED manufacturing through partnerships,…
CHPT forecasts strong start to 2025 after record profits, optimistic about US demand growth
Increasing demand for high-performance computing (HPC) chip testing, particularly driven by AI applications, led Chunghwa Precision Test Tech to achieve…